WIPO Side event: Appraising Progress of WHO’s COVID-19 Technology Access Pool (C-TAP)

DATE: Tuesday, 22 September 2020 TIME: 18:00 CEST to 19:00 CEST CONVENER: Knowledge Ecology International (KEI) REGISTRATION: Please contact thiru [at] keionline.org On occasion of the 61st Series of Meetings of the WIPO General Assembly, Knowledge Ecology International (KEI) is… Continue Reading

Joint letter to WHO formally requesting the R&D Observatory to play a more relevant role in the COVID-19 response

On Friday, 28 August 2020, six groups including Corporación Innovarte, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos wrote a joint letter to the World Health Organization’s (WHO) Chief Scientist, Dr. Soumya Swaminathan,… Continue Reading

BARDA is investigating Moderna’s failures to disclose BARDA funding in patent applications

(More on Moderna here: https://www.keionline.org/moderna) KEI received a letter Dr. Gary Disbrow, the Acting Director of BARDA, just before noon today. BARDA2KEI.Moderna.Patent.Disclosures.20200903 The BARDA investigation follows the announcement on Saturday that DARPA was also investigating DARPA’s failures to disclose DARPA… Continue Reading

Italy undertakes bold measures on transparency by adopting the Pricing and Reimbursement Decree

On Friday, 24 July 2020, Italy officially published the long-anticipated Pricing and Reimbursement Decree in the Gazzetta Ufficiale della Repubblica Italiana setting in motion Italy’s place as the first country to implement the WHO transparency resolution (WHA72.8). In statement before… Continue Reading

KEI and Public Citizen request BARDA to address Moderna’s noncompliance with COVID-19 vaccine contract term

(More on Moderna here: https://www.keionline.org/moderna) On July 31, 2020, Knowledge Ecology International and Public Citizen sent Biomedical Advanced Research and Development Authority (BARDA) a letter asking BARDA to enforce a term of Moderna’s billion dollar contract with BARDA to develop… Continue Reading

KEI receives seven new contracts for COVID 19 research from BARDA and DOD, including five using “Other Transactions Authority” that weaken or eliminate Bayh-Dole and FAR Safeguards

KEI has a number of outstanding requests under the United States Freedom of Information Act (FOIA) for contracts related to biomedical innovations to control or treat the COVID-19 pandemic. On Thursday, June 25, and Friday, June 26, we received a… Continue Reading